CA-SCIENTIST.COM
Scientist.com, the life science industry’s leading online marketplace for outsourced research, announced the successful conclusion of a four-part podcast series on human biological samples and biobanking. The four guests offered thoughtful insights and ideas from an academic, pharmaceutical and small business perspective. The episodes were hosted by Mendelspod , one of the life science industry’s leading podcasts.
“This is the second time we’ve covered human biospecimen quality and governance on this show, which tells me that people are interested and looking for answers,” said Theral Timpson, Host, Producer and Co-Founder of Mendelspod. “What Scientist.com is doing—offering a self-regulatory solution within the life sciences—is a practical first step toward filling an important gap.”
The series featured experts in biospecimen regulation, biobanking and compliance, including Carolyn Compton, PhD, Chief Medical Officer of the National Biomarker Development Alliance and ASU professor; Shannon McCall, PhD, Director of the Precision Cancer Medicine Initiative at the Biorepository and Precision Pathology Center at Duke University; Kirstin Goldring, PhD, Counselor at the European Society for Biopreservation and Biobanking and member of ISBER; and Matt McLoughlin, Vice President of Compliance at Scientist.com. Topics covered ranged from the sustainability of biobanks to a discussion of COMPLi™ —Scientist.com’s proprietary compliance framework for overseeing the acquisition of human biological samples for research.
“It was an honor to be included amongst a group of such distinguished and knowledgeable speakers on the topic of human biospecimen quality and biobanking,” commented McLoughlin. “Forums like these raise awareness regarding the sustainability of biobanks and help us create a more standardized set of rules governing human biospecimen acquisition.”
All podcasts are accessible free of charge at https://mendelspod.com/ .
About Scientist.com
Scientist.com is the world's leading marketplace for outsourced research. The marketplace simplifies the entire research sourcing process, saving time and money and providing access to the latest innovative tools and technologies while maintaining full compliance with an organization’s procurement policies. Scientist.com operates private enterprise marketplaces for most of the world’s major pharmaceutical companies, VWR and the US National Institutes of Health (NIH). Since its founding in 2007, Scientist.com has raised more than $33 million from Leerink Transformation Partners, 5AM Ventures, Heritage Provider Network, Bootstrap Ventures and Hollywood producer Jack Giarraputo, among others. Visit scientist.com to learn more.
Join Scientist.com on social media: YouTube , LinkedIn , Twitter , Facebook , Google+ and Instagram .
View source version on businesswire.com: https://www.businesswire.com/news/home/20181008005095/en/
Contact:
Media Contact: Scientist.com Sean Preci Director of Communications +1 858-455-1300, ext. 401 marketing@scientist.com
Link:
Social Media:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
LIBERTEX29.3.2024 06:26:33 CET | Press release
PAN Finance Names Libertex ‘Global CFD Broker of the Year’
MIDEA-GROUP29.3.2024 02:40:30 CET | Press release
Midea Group releases its first-ever ESG brand story with an unexpected VIP visit highlighting its commitment to sustainability.
NY-DC-ADMINISTRATION28.3.2024 21:15:26 CET | Press release
DC Secretary Announces Annual Determinations Committees Outcome
CA-HTEC/G2-RISK28.3.2024 17:03:32 CET | Press release
Faster Recoveries, Improved Security: HTEC and G2 Risk Solutions Join Forces to Advance Bankruptcy Management
YCVB28.3.2024 16:01:31 CET | Press release
The reopening of the Yokohama Museum of Art adds another innovative and distinctive venue for events in Yokohama
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom